Recombinant bordetella bronchiseptica strain, vaccine and use
A technology of Bordetella blood and bronchi, which is applied in the direction of bacteria, antibacterial drugs, bacterial antigen components, etc., can solve biological safety problems and other problems, and achieve the effect of convenient immune operation, broad market application prospects, and good immune protection
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0041] 1. Primer design and PCR amplification
[0042] According to the reported whole genome sequence of Bordetella bronchiseptica RB50 (Parkhill J., 2003, Nature) (refer to the gene sequence of Genbank accession number AF315119), two pairs of primers were designed (all primers were provided by Nanjing GenScript Biotechnology Co., Ltd. Synthesis) to amplify the upstream homology arm and downstream homology arm of the aroA gene respectively, the size of the amplified fragments are 1388bp and 1383bp respectively, design Kpn I and Sal I restriction sites at both ends of the upstream arm, and design Hind at both ends of the downstream arm III and Sac I restriction sites. According to the reported toxin-producing Pasteurella multocida strain HN-13 (Tang Xianchun. Isolation, Identification and Biological Characteristics of Pasteurella multocida. [Master's Dissertation], CNKI http: / / www .cnki.net / kcms / detail / detail.aspx?dbcode=cmfd&dbname=cmfd2005&filename=2004138308.nh&uid=WEEvREc...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com